Organization (Hospital)
MARIA CECILIA HOSPITAL S.P.A.
ClinicalTrials.gov lists MARIA CECILIA HOSPITAL S.P.A. as lead sponsor of 17 trials. It has 1 active development program.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 1 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 2.4 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers MARIA CECILIA HOSPITAL S.P.A.: 17 lead-sponsored trials and 2 legal-entity registrations. The parent company on record for MARIA CECILIA HOSPITAL S.P.A. is GRUPPO VILLA MARIA S.P.A O ANCHE G.V.M. S.P.A., which does not have its own page on this site.
Disease areas (20)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Atrial Fibrillation | 4 |
| Atherosclerosis | 2 |
| Chronic Limb-Threatening Ischemia | 2 |
| Diabetes Mellitus | 2 |
| Diabetic Foot | 2 |
Showing 5 of 20 disease areas.
Trials by start year as sponsor or collaborator (12)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 3 |
| 2024 | 3 |
| 2023 | 2 |
| 2022 | 4 |
| 2021 | 2 |
| 2019 | 1 |
| 2018 | 1 |
| 2017 | 1 |
| 2014 | 1 |
Showing 10 of 12 years.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (1)
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| Blood analysis | Obesity | Not reported | 1 |
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 50% hit target (n=6) | 17% on time (n=6) |
Journals published in (12)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| European heart journal | 3 |
| Diabetes/metabolism research and reviews | 2 |
| JACC. Cardiovascular interventions | 2 |
| Journal of the American College of Cardiology | 2 |
| The New England journal of medicine | 2 |
Showing 5 of 12 journals.
Organization relationships (8)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Azienda Ospedaliero Universitaria Maggiore della Carita | Co sponsors trial with | 1 |
| Istituti di Ricovero e Cura a Carattere Scientifico | Co sponsors trial with | 1 |
| University Hospital Padova | Co sponsors trial with | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Co sponsors trial with | 1 |
| San Camillo Hospital, Rome | Co sponsors trial with | 1 |
Showing 5 of 8 relationships.
Latest dated events (21)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-10-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-11-03 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-06-25 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-05-28 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-11-11 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 21 events.
Biomarkers this organization publishes on (60)
Shown in this order: most publications first.
Showing 5 of 60 biomarkers.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, approved assets, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarker capability evidence.